{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:34:56Z","timestamp":1761744896992,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.dsx.2022.102407","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T14:54:44Z","timestamp":1642604084000},"page":"102407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of COVID 19 pneumonia on hyperglycemia: Is it different from non COVID pneumonia?"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8991-1235","authenticated-orcid":false,"given":"Daniel B.","family":"Knox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliotte L.","family":"Hirshberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Orme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ithan","family":"Peltan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Lanspa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2022.102407_bib1","doi-asserted-by":"crossref","first-page":"E736","DOI":"10.1152\/ajpendo.00124.2020","article-title":"COVID-19 pandemic, coronaviruses, and diabetes mellitus","volume":"318","author":"Muniyappa","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.dsx.2022.102407_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dsx.2020.04.004","article-title":"Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes, Metab Syndrome"},{"key":"10.1016\/j.dsx.2022.102407_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57010068","article-title":"Glycemia, beta-cell function and sensitivity to insulin in mildly to critically ill covid-19 patients","volume":"57","author":"Ilias","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.dsx.2022.102407_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13054-015-0908-7","article-title":"Time in blood glucose range 70 to 140 mg\/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults","volume":"19","author":"Krinsley","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.dsx.2022.102407_bib5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.chest.2019.05.016","article-title":"Percentage of time in range 70 to 139 mg\/dL is associated with reduced mortality among critically ill patients receiving IV insulin infusion","volume":"156","author":"Lanspa","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.dsx.2022.102407_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.annemergmed.2015.02.003","article-title":"Impact of an electronic clinical decision support tool for emergency department patients with pneumonia","volume":"66","author":"Dean","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.dsx.2022.102407_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.dsx.2022.102407_bib8","article-title":"Maintaining blood glucose levels in range (70-150 mg\/dL) is difficult in COVID-19 compared to non-COVID-19 ICU patients-A retrospective analysis","volume":"9","author":"Kapoor","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.dsx.2022.102407_bib9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMc2018688","article-title":"New-onset diabetes in covid-19","volume":"383","author":"Rubino","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2022.102407_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.dsx.2022.102407_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2337\/db12-0177","article-title":"Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice","volume":"62","author":"Takeda","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2022.102407_bib12","doi-asserted-by":"crossref","first-page":"652","DOI":"10.7150\/ijbs.10250","article-title":"Role of the renin-angiotensin system, renal sympathetic nerve system, and oxidative stress in chronic foot shock-induced hypertension in rats","volume":"11","author":"Dong","year":"2015","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.dsx.2022.102407_bib13","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1007\/s00018-007-6228-6","article-title":"Angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"64","author":"Imai","year":"2007","journal-title":"Cell Mol Life Sci"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402122000212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402122000212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:17:32Z","timestamp":1761729452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402122000212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1871402122000212"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2022.102407","relation":{},"ISSN":["1871-4021"],"issn-type":[{"type":"print","value":"1871-4021"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of COVID 19 pneumonia on hyperglycemia: Is it different from non COVID pneumonia?","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2022.102407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102407"}}